{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:09Z","timestamp":1786372869745,"version":"build-2736575974"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"DOI":"10.7759\/cureus.85255","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:57:34Z","timestamp":1748919454000},"source":"Crossref","is-referenced-by-count":3,"title":["A Case of Refractory Hidradenitis Suppurativa Successfully Treated With Upadacitinib"],"prefix":"10.7759","author":[{"given":"Itsuki","family":"Takei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Shibata-Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoma","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tokito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.32746","article-title":"The disease burdens of self-diagnosed hidradenitis suppurativa patients in Japan: a cross-sectional web-based survey","volume":"104","author":"Hayama K","year":"2024","unstructured":"Hayama K, Okazaki M, Akiyama T, Morita K, Nomura T. The disease burdens of self-diagnosed hidradenitis suppurativa patients in Japan: a cross-sectional web-based survey. Acta Derm Venereol. 2024, 104:adv32746. 10.2340\/actadv.v104.32746","journal-title":"Acta Derm Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_15_2023","article-title":"Janus-kinase inhibitors in dermatology: a review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease","volume":"90","author":"Huang MY","year":"2023","unstructured":"Huang MY, Armstrong AW. Janus-kinase inhibitors in dermatology: a review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease. Indian J Dermatol Venereol Leprol. 2023, 90:30-40. 10.25259\/IJDVL_15_2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.07.172","article-title":"43799 efficacy and safety of upadacitinib in moderate-to-severe hidradenitis suppurativa: a phase 2, randomized, placebo-controlled study","volume":"89","author":"Kimball AB","year":"2023","unstructured":"Kimball AB, Ackerman L, Schlosser BJ, et al.. 43799 efficacy and safety of upadacitinib in moderate-to-severe hidradenitis suppurativa: a phase 2, randomized, placebo-controlled study. J Am Acad Dermatol. 2023, 89:42. 10.1016\/j.jaad.2023.07.172","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.06.019","article-title":"A systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance","volume":"141","author":"Frew JW","year":"2021","unstructured":"Frew JW, Marzano AV, Wolk K, Join-Lambert O, Alavi A, Lowes MA, Piguet V. A systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance. J Invest Dermatol. 2021, 141:316-324.e2. 10.1016\/j.jid.2020.06.019","journal-title":"J Invest Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646680","article-title":"Targeting JAK\/STAT signalling in inflammatory skin diseases with small molecule inhibitors","volume":"47","author":"Welsch K","year":"2017","unstructured":"Welsch K, Holstein J, Laurence A, Ghoreschi K. Targeting JAK\/STAT signalling in inflammatory skin diseases with small molecule inhibitors. Eur J Immunol. 2017, 47:1096-107. 10.1002\/eji.201646680","journal-title":"Eur J Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371374-a-case-of-refractory-hidradenitis-suppurativa-successfully-treated-with-upadacitinib","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:57:34Z","timestamp":1748919454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371374-a-case-of-refractory-hidradenitis-suppurativa-successfully-treated-with-upadacitinib"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.85255","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}